Jim Cramer Discussed 18 Companies That Hit $100 Billion in Market Cap in 2024

4. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 92

Cramer likes Boston Scientific Corporation (NYSE:BSX) and said that it is a “superior company”.

“Now it was a big cluster with gains in the mid-fifties… Finally, there’s Boston Scientific, which makes minimally invasive medical devices. We’ve had them on… Some would say it just builds a better mousetrap, crude and somewhat denigrating but true, a superior company.”

Boston Scientific (NYSE:BSX) designs, manufactures, and markets medical devices for various interventional specialties, offering products for various conditions. The company’s growth prospects are furthered by its continued focus on acquiring and integrating other medical technology companies. In November, it completed the acquisition of Axonics, Inc., a company specializing in devices to treat urinary and bowel dysfunction.

The transaction, valued at $3.7 billion in equity, was financed in part by cash raised earlier in the year, which is expected to generate about $100 million in nonrecurring interest income for the company in 2024. Additionally, in the same month, it agreed to acquire Cortex, Inc., a company focused on developing diagnostic mapping solutions for atrial fibrillation (AF), a heart rhythm disorder. The deal, which is expected to close in the first half of 2025, complements the company’s efforts in advancing its cardiac portfolio.

Also, at the end of November, Boston Scientific (NYSE:BSX) announced another agreement to acquire Intera Oncology Inc., a medical device company specializing in the treatment of liver cancer through its hepatic artery infusion pump and chemotherapy drug. This acquisition is also expected to be completed by mid-2025, further expanding Boston Scientific’s reach in the oncology sector.